Should sporicidal agents be ammunition in the C. diff fight?

Hospitals across the country struggle with keeping Clostridium difficile at bay — according to Consumer Reports‘ recent rankings, more than one-third of U.S. hospitals had C. diff rates worse than the national benchmark.

Advertisement

One of the reasons C. diff rates are so difficult to control is because C. diff itself is persistent and hard to kill. For instance, alcohol-based hand sanitizer cannot kill the bacteria; instead, soap and water must be used. Additionally, standard Environmental Protection Agency-registered hospital disinfectants are not effective against C. diff, according to the CDC.

In fact, the CDC recommends using an EPA-registered disinfectant with a sporicidal claim to clean and disinfect surfaces and devices to control the spread of C. diff.

Learn more about the indiscriminate use of sporicidal agents to fight C. diff in an upcoming webinar, sponsored by Clorox. Register for the Nov. 1 webinar here.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.